Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALCIMEDICA

1.57
-0.0800-4.85%
Volume:32.92K
Turnover:54.42K
Market Cap:21.94M
PE:-1.03
High:1.72
Open:1.69
Low:1.56
Close:1.65
Loading ...

BRIEF-Calcimedica Announces Publication In The American Journal Of Nephrology Discussing Design

Reuters
·
Yesterday

CalciMedica Inc. Announces Phase 2 KOURAGE Trial of Auxora™ for Acute Kidney Injury with Respiratory Failure

Reuters
·
Yesterday

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 Kourage Trial of Auxora™ in Aki With Respiratory Failure

THOMSON REUTERS
·
Yesterday

Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares of CalciMedica Inc

Reuters
·
14 Jun

Eric W. Roberts, Chief Business Officer, Reports Acquisition of Common Shares of CalciMedica Inc

Reuters
·
10 Jun

CalciMedica Inc. Appoints Baker Tilly as New Auditor Following Moss Adams Merger

Reuters
·
06 Jun

CalciMedica Inc. CFO Stephen Bardin Reports Acquisition of Common Shares

Reuters
·
04 Jun

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
15 May

CalciMedica Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

CalciMedica Q1 EPS $(0.36) Misses $(0.31) Estimate

Benzinga
·
14 May

CalciMedica Inc: Cash Position Expected to Fund Operations Into Mid-2026

THOMSON REUTERS
·
14 May

CalciMedica Inc: Qtrly Loss per Share $0.36

THOMSON REUTERS
·
14 May

CalciMedica Q1 Income From Operations USD -6.497 Million

THOMSON REUTERS
·
14 May

CalciMedica Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
09 May

CalciMedica Announces Presentations at Upcoming Medical Meetings

PR Newswire
·
17 Apr

CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

PR Newswire
·
01 Apr

CalciMedica Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

BRIEF-Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates

Reuters
·
27 Mar

CalciMedica Inc - Cash Position Expected to Fund Operations Into Mid-2026

THOMSON REUTERS
·
27 Mar